Created at Source Raw Value Validated value
June 25, 2024, noon usa

1. erroneous inclusion (violation of inclusion/non-inclusion criteria). 2. individual intolerance to the investigational drug. 3. refusal of the patient to continue participating in the study/withdrawal of informed consent by the patient. 4. termination of the study.

1. erroneous inclusion (violation of inclusion/non-inclusion criteria). 2. individual intolerance to the investigational drug. 3. refusal of the patient to continue participating in the study/withdrawal of informed consent by the patient. 4. termination of the study.

Nov. 16, 2021, 6:30 p.m. usa

erroneous inclusion (violation of inclusion/non-inclusion criteria). individual intolerance to the investigational drug. refusal of the patient to continue participating in the study/withdrawal of informed consent by the patient. termination of the study.

erroneous inclusion (violation of inclusion/non-inclusion criteria). individual intolerance to the investigational drug. refusal of the patient to continue participating in the study/withdrawal of informed consent by the patient. termination of the study.

March 5, 2021, 12:31 a.m. usa

1. erroneous inclusion (violation of inclusion/non-inclusion criteria). 2. individual intolerance to the investigational drug. 3. refusal of the patient to continue participating in the study/withdrawal of informed consent by the patient. 4. termination of the study.

1. erroneous inclusion (violation of inclusion/non-inclusion criteria). 2. individual intolerance to the investigational drug. 3. refusal of the patient to continue participating in the study/withdrawal of informed consent by the patient. 4. termination of the study.